(NASDAQ:GLBZ), GLEN BURNIE, Md., Dec. 12, 2025 (GLOBE NEWSWIRE) — Glen Burnie Bancorp (“Bancorp”) (NASDAQ: GLBZ), the bank holding Bancorp for The Bank of Glen Burnie (“Bank”), today announced that Bancorp's board of directors (the “Board”) has approved the voluntarily delisting of Bancorp's common stock (and related common stock purchase rights) from The Nasdaq Capital […]
(CNSX:PSE.CN),(Boerse Frankfurt – Freiverkehr:PNX),(CNSX:PSE), TORONTO, Dec. 12, 2025 (GLOBE NEWSWIRE) — Pasinex Resources Limited (CSE: PSE; FSE: PNX) (“Pasinex” or the “Company”) is pleased to announce that Turkiye's General Directorate of Mining and Petroleum Affairs (“MAPEG”) has approved the transfer of shares in Horzum Arama ve Madencilik AS (“Horzum AS”) from Kurmel Madencilik to Pasinex
Financing funds the global Phase 2b clinical trial in atopic dermatitis and Phase 2 clinical program in molluscum contagiosum AlphynBiologics, Inc., a clinical-stage dermatology company developing first-in-class Multi-Target Therapeutics®, today announced the close of its $25 million, twice-oversubscribed Series B financing. Proceeds will fund the Phase 2b global clinical trial of Alphyn's lead drug candidate,
Ractigen Therapeutics, a pioneering developer of small activating RNA (saRNA) therapeutics, today announced the successful dosing of the first patient in its investigator-initiated trial (IIT) of RAG-18 at Peking Union Medical College Hospital (PUMCH) in Beijing. This important milestone represents a significant step forward in developing new therapies for Duchenne Muscular Dystrophy (DMD), providing a
Peijia Medical (9996.HK), a leading Chinese domestic company in the high-growth transcatheter valve therapeutics and neurovascular interventions markets, announced that its TaurusTrio Transcatheter Aortic Valve (TAV) system received approval from the National Medical Products Administration (NMPA) of China on December 11, 2025. https://mma.prnewswire.com/media/2166853/PEIJIA_Logo_Logo.jpg The TaurusTrio TAV system is developed and manufactured by Peijia Medical under
HONG KONG, CHINA / ACCESS Newswire / December 12, 2025 / DR H recently announced a strengthened strategic direction focused on elevating the integration of fashion and technology within the smart wearable market. Centered on the concept of "AI + Health," the brand aims to advance its design philosophy and expand user adoption of smart
Serve Robotics Builds 2,000 Autonomous Delivery Robots, Creating Largest Sidewalk Delivery Fleet in the U.S. Active fleet grew twentyfold in one year, fueled by expanding partnerships with top restaurants, retailers, and delivery platforms GlobeNewswire December 12, 2025 SAN FRANCISCO, Dec. 12, 2025 (GLOBE NEWSWIRE) — Serve Robotics Inc. (Nasdaq: SERV), a leading autonomous sidewalk delivery
Glen Burnie Bancorp Announces Intended Voluntary Delisting from Nasdaq and Termination of SEC Registration GlobeNewswire December 12, 2025 GLEN BURNIE, Md., Dec. 12, 2025 (GLOBE NEWSWIRE) — Glen Burnie Bancorp (“Bancorp”) (NASDAQ: GLBZ), the bank holding Bancorp for The Bank of Glen Burnie (“Bank”), today announced that Bancorp's board of directors (the “Board”) has approved
Streamex Corp. (NASDAQ: STEX) to Provide Corporate Update Webinar Highlighting 2025 Milestones and 2026 Strategic Roadmap on December 16th at 11:00am EST GlobeNewswire December 12, 2025 LOS ANGELES, Dec. 12, 2025 (GLOBE NEWSWIRE) — Streamex Corp. (“Streamex” or the “Company”) (NASDAQ: STEX), a leader in institutional-grade tokenization and digital asset infrastructure, today announced that it
Applied Materials Announces Cash Dividend GlobeNewswire December 12, 2025 SANTA CLARA, Calif., Dec. 12, 2025 (GLOBE NEWSWIRE) — Applied Materials, Inc. today announced that its Board of Directors has approved a quarterly cash dividend of $0.46 per share payable on the company's common stock. The dividend is payable on March 12, 2026 to shareholders of